EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 79 filers reported holding EDGEWISE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $251 | +143.7% | 43,871 | +228.6% | 0.00% | – |
| Q2 2023 | $103 | +15.7% | 13,349 | -0.3% | 0.00% | – |
| Q1 2023 | $89 | -58.8% | 13,384 | -44.5% | 0.00% | – |
| Q4 2022 | $216 | -99.9% | 24,115 | +50.5% | 0.00% | – |
| Q3 2022 | $158,000 | +23.4% | 16,025 | 0.0% | 0.00% | – |
| Q2 2022 | $128,000 | -53.1% | 16,025 | -43.1% | 0.00% | – |
| Q1 2022 | $273,000 | -3.2% | 28,174 | +52.6% | 0.00% | – |
| Q4 2021 | $282,000 | +58.4% | 18,460 | +72.1% | 0.00% | – |
| Q3 2021 | $178,000 | -21.2% | 10,725 | +1.2% | 0.00% | – |
| Q2 2021 | $226,000 | – | 10,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $15,071,000 | 7.43% |
| Cormorant Asset Management, LP | 4,682,874 | $45,424,000 | 3.49% |
| Novo Holdings A/S | 5,587,207 | $54,196,000 | 2.86% |
| Orbimed Advisors | 13,944,680 | $135,263,000 | 2.19% |
| Opaleye Management Inc. | 303,000 | $2,939,000 | 0.91% |
| DAFNA Capital Management LLC | 356,750 | $3,460,000 | 0.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $38,151,000 | 0.85% |
| EcoR1 Capital, LLC | 2,359,808 | $22,890,000 | 0.72% |
| RA Capital Management | 2,613,623 | $25,352,000 | 0.55% |
| HighVista Strategies LLC | 59,733 | $579,000 | 0.37% |